. . . . . . . . . "\"Tolcapone tablets are contraindicated in patients with liver disease, in patients who were withdrawn from Tolcapone tablets because of evidence of Tolcapone tablets-induced hepatocellular injury or who have demonstrated hypersensitivity to the drug or its ingredients. Tolcapone tablets is also contraindicated in patients with a history of nontraumatic rhabdomyolysis or hyperpyrexia and confusion possibly related to medication (see PRECAUTIONS: Events Reported With Dopaminergic Therapy\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "fpVjyWYpDUKtUGUbzH06ZJei+pKoE+vvozUIgUyXTHf3nXQE/mMIhb0KHtpJnQLXMFufPT5Do+ebaJS60n92MXyWwB9xoWmbvPku/PONA1IZV7uSHZ9dOC2XJDAXEEknJyrAH6Jz9BYGOUorcHpLMSd61nasNDEJ68evDAdz3XA=" . . "2021-08-23T19:05:14.986+02:00"^^ . . . . .